Close Menu

artificial intelligence

The multi-stage drive to create a next-generation computing system will support a new pathogen research center that promises to create 7,500 jobs and advance biomedicine.

The approach applies deep learning and could potentially be used to identify people with early-stage disease when therapies may have more of an effect.

Under their 10-year partnership, IBM will install an early instance of its Quantum System One at Cleveland Clinic to promote AI-driven life sciences discovery.

The Korean molecular diagnostics firm, a spinoff from genomic services provider Macrogen, also announced plans for an IPO early next year.

The companies initially plan to expand the commercialization of Sophia's DDM analytics platform and Hitachi's digital healthcare technology in certain geographic areas.

The California-based firms also plan to collaborate on advancing genomics and artificial intelligence-guided oncology tools. 

Former Google CEO Eric Schmidt and wife Wendy Schmidt donated $150 million to endow the center, which will convene international academic and commercial collaborators.

The firms will launch Ocean Genomics' txome.ai transcriptome analysis and biomarker platform as a cloud-based and on-premises tool in Korea.

North America already is the largest market for the startup maker of polygenic risk scoring software that was founded in Rome.

Tempus will assist Texas Oncology subsidiary Precision Health Informatics in mining its database for precision oncology insights to inform research.

Pages

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.